Anabolic Hormone replacement, a new era!
Hormone replacement market (HRT) is used for replenishing the hormones that are present in low levels in the human body. This treatment is particularly favourable for patients with growth hormone deficiency, women nearing menopause and elderly people suffering from hypogonadism.
Summary
·
The global healthcare
information software market reached a value of
approximately US$ 3.9 Billion in 2017.
·
The market value is projected to reach around US$ 5.9 Billion
by 2023,
registering a CAGR of 7.2%
during 2018-2023.
·
Hormone replacement therapy (HRT) is used for replenishing
the hormones
that are present in low
levels in the human body.
·
Treatment is particularly favourable for patients with growth
hormone
deficiency, women nearing
menopause and elderly people suffering from
hypogonadism.
Major Regions
Based
on product type, estrogen replacement therapy accounts for the majority of the
global share. Other types include human growth hormone replacement therapy,
testosterone replacement therapy, thyroid replacement therapy and others.
Key Players
·
Abbott Laboratories
·
Bayer AG
·
Eli Lilly & Company
·
Roche
·
Hisamitsu Pharmaceutical Co. Inc.
·
Merck
·
Mylan
·
Novartis
·
Novo Nordisk and Pfizer.
Category of Report:
Related Reports:
Peroxisome Proliferator Activated Receptor Delta (NUCI or Nuclear Hormone Receptor 1 or Nuclear
Receptor Subfamily 1 Group C Member 2 or Peroxisome Proliferator Activated Receptor Beta or NR1C2 or PPARD) - Pipeline Review, H2 2018
Contact Details:
Aarkstore Enterprise
Phone: +91 - 22 2756 4963
24/7 Online Support: +91 9987295242
Email: contact@aarkstore.com
Phone: +91 - 22 2756 4963
24/7 Online Support: +91 9987295242
Email: contact@aarkstore.com
Our website: https://www.aarkstore.com
Comments
Post a Comment